Syuhada Zulkifli
Guardant Expands Cancer Screening with Blood Test
Guardant Health expands cancer screening with a blood test to catch disease before symptoms appear using cancer screening methods.
AMS sale to H B Fuller approved
AMS sale to H B Fuller approved for 715 million pounds, expanding medical earnings before interest.
Philips shareholder to raise stake to 22 percent
Philips shareholder to raise stake to 22% as Dutch medical tech firm signals vote of confidence in its strategy.
CMS seeks feedback on breakthrough device coverage
CMS seeks feedback on a proposal to accelerate coverage for breakthrough devices and eliminate long delays in patient access to medical technology.
Schein Ousts Three Top Executives Suddenly
Schein ousts top executives suddenly to simplify business and improve execution on its goals with new leadership team.
FDA Reconsiders Its Use of Artificial Intelligence
FDA reconsiders artificial intelligence use after commissioner departure, focusing on ai strategy and implementation, while ensuring regulatory compliance.
Boston Scientific Plans Restructuring $800M Charges Expected
Boston Scientific restructuring plan will incur up to $800 M in pre‑tax charges as the company shifts production and cuts jobs to…
User Account Blocked by Administrators
Prevent drug diversion with multidisciplinary auditing and procurement checks beyond diversion surveillance software effectively.
User Account Blocked by Social Media Platform
Regular coffee intake is linked to lower disease risk, with up to 400 mg of caffeine daily considered safe for most adults,…
User Account Blocked by Moderators
Sacituzumab govitecan is a new first-line treatment option for breast cancer patients with metastatic triple-negative breast cancer.